Exponent has expanded the scope of its ISO/IEC 17025:2017 accreditation at its Natick, Massachusetts facility under the American Association for Laboratory Accreditation (A2LA). The expansion includes new microbiological testing capabilities for industry standard methods used in biomedical, pharmaceutical, and consumer products.
Additionally, the Natick facility has enhanced its accredited capabilities for evaluating the corrosion behavior of medical devices implanted in the human body and assessing the safety of laser and optical radiation. These accreditations ensure that Exponent's testing methods are developed and validated to state-of-the-art, consensus-based industry standards.
This expanded accreditation reinforces Exponent's commitment to quality and excellence in supporting clients with complex challenges, particularly in highly regulated sectors. The enhanced capabilities position the firm to address evolving safety challenges in areas such as AR/VR, consumer electronics, and the automotive industries, alongside its core medical device and pharmaceutical testing services.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.